Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia-Reference-Cited by-同舟云学术

Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia

Published:2017-05-24 Issue:7 Volume:65 Page:1222-1225
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Simon Matthew S,Westblade Lars F,Dziedziech Alexis,Visone Joseph E,Furman Richard R,Jenkins Stephen G,Schuetz Audrey N,Kirkman Laura A

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/65/7/1222/19918672/cix477.pdf

Reference15 articles.

1. Persistent and relapsing babesiosis in immunocompromised patients;Clin Infect Dis,2008

2. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America;Clin Infect Dis,2006

3. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection;Clin Infect Dis,2010

4. A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse;Nat Microbiol,2016

5. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action;Nat Commun,2014

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the inhibitory effects of sitamaquine on Babesia infections;Parasitology International;2024-12

2. In vitro efficacy of next-generation dihydrotriazines and biguanides against babesiosis and malaria parasites;Antimicrobial Agents and Chemotherapy;2024-09-04

3. Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management;Current Opinion in Infectious Diseases;2024-08-02

4. Tafenoquine for Relapsing Babesiosis: A Case Series;Clinical Infectious Diseases;2024-05-30

5. In Vitro Efficacy of Next Generation Dihydrotriazines and Biguanides Against Babesiosis and Malaria Parasites;2024-03-21